890P Prospective comparison of RECIST and alternative response assessment criteria in the evaluation of metastatic renal cell cancer patients from phase II of the multi-centre randomised STAR trial.
Kelly-Morland, C Zhong, J Goh, V Wah, T Ralph, C Patel, P Nathan, P Eisen, T Gregory, W
Kelly-Morland, C
Zhong, J
Goh, V
Wah, T
Ralph, C
Patel, P
Nathan, P
Eisen, T
Gregory, W
Citations
Altmetric:
Abstract
Description
Date
2017-09
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
890P Prospective comparison of RECIST and alternative response assessment criteria in the evaluation of metastatic renal cell cancer patients from phase II of the multi-centre randomised STAR trial. 2017, 28(suppl_5): Ann Oncol